<DOC>
	<DOCNO>NCT00939835</DOCNO>
	<brief_summary>- Objective : - The objective study compare rate extent absorption Test Product , Citalopram Hydrobromide 40 mg ( Torrent Pharmaceutical Limited ) Reference Product , RLD Tablets 40 mg ( Forest Pharmaceuticals Inc , Missouri ) feed condition - Study Design : - Randomized , Single Dose , Open Label , Non-Replicate , Two-period , Two-treatment , Two- Sequence Crossover Bioequivalence Study compare Citalopram Hydrobromide Tablets 40 mg ( manufactured Torrent Pharmaceuticals Ltd ) . With RLD Tablets 40 mg ( manufactured Forest Pharmaceuticals Inc Missouri ) 24+2 normal healthy male subject wash period 15 day two study period , feed condition .</brief_summary>
	<brief_title>Study Comparing Citalopram Hydrobromide Tablets 40 mg ( Torrent Pharmaceuticals Ltd ) RLD Tablets 40 mg ( Manufactured By Forest Pharmaceuticals Inc , Missouri ) 24+2 Normal Healthy Male Subjects Fed Condition</brief_title>
	<detailed_description />
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Male female subject range 18 45 year age . Body weight within Â± 15 % weight range related height , per Life Insurance Corporation ( LIC ) Chart . ( Appendix A ) No abnormal finding determine baseline history , physical examination , vital sign ( blood pressure , pulse rate , respiration rate body temperature ) hematological test , serum chemistry , urinalysis , ECG Chest Xray . Subjects value above/below reference range , ( Appendix J ) hematological , serum chemistry urine analysis value clinically correlate sign symptom . These subject include find asymptomatic . Willingness follow , protocol requirement , evidence write , informed consent . Agreeing , use medication ( prescription counter ) , include vitamin mineral 15 day prior study &amp; course study . No history presence significant alcoholism drug abuse past one year . Subjects preferably nonsmoker . If moderate smoker include ( less 10 cigarette per day ) per guideline identify documented history take form CRF . Requiring medication ailment . Any medical surgical condition , might significantly interfere function gastrointestinal tract , bloodforming organ etc . History cardiovascular , renal , hepatic , ophthalmic , pulmonary , neurological , metabolic psychiatric disease . Participation clinical drug study Bioequivalence study 90 day prior present study . History malignancy serious disease . Refusal abstain food ten ( 10 ) hour prior study drug administration first day study period four ( 4 ) additional hour , post dose . Refusal abstain water one ( 1 ) hour prior study drug administration first day study period one ( 1 ) additional hour , post dosing . Any contraindication blood sampling . Smoking consumption tobacco product study . Use xanthinecontaining beverage food 48 hour prior drug dose . Blood donation 30 day prior commencement study . Subjects positive HIV test . Subjects positive HbsAg HepatitisC test . Known history hypersensitivity Citalopram relate drug . Pregnant lactate woman . At time screening , prior enrollment , presence pregnancy confirm urine pregnancy test . Just prior commencement study ( period ) , presence pregnancy confirm urine pregnancy test . Female subject confirm use birth control measure , date screening till completion second period study . Abstinence , barrier method ( condom , diaphragm , etc . ) acceptable . Use hormonal contraceptive either oral implant acceptable . Female subject whose menstruation cycle coincides study period . History drug abuse past one year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>